Evaluation of California's SB 19 Pupil Nutrition Act
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00067847|
Recruitment Status : Completed
First Posted : September 1, 2003
Last Update Posted : January 13, 2010
|Condition or disease||Intervention/treatment||Phase|
|Obesity||Behavioral: State-directed nutrition policy change||Not Applicable|
Four California school districts will be randomized to early implementation of California's SB 19 Pupil Nutrition Act or to business as usual.
The nutrition provisions in SB19 include assuring that NO elementary school sells carbonated beverages at any time and that no middle schools sell carbonated beverages until after the end of the lunch hour each day. The nutrition provisions also include some restrictions on the sale of high-fat, high-sugar snack foods as well as encouragement to make fruits and vegetables more available to students. The legislation further encourages school districts to invest more heavily in providing students with opportunities to be physically active. High schools are NOT affected by this legislation.
Over 5000 4th, 5th, and 7th graders from 28 schools will be evaluated at baseline, 4-month and 16-month follow-up in order to determine if the SB 19 nutrition and physical activity policies have had an impact on students' risk of excess body weight. The principal outcome measure is sex- and age-adjusted BMI percentile as determined from the CDC growthchart percentiles. Other measures include waist circumference, time to complete one mile run/walk, and blood pressure.
The impact of early implementation of SB 19 on academic achievement will also be assessed, using students' standardized math and language arts achievement test scores.
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||5020 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Study Start Date :||July 2003|
|Study Completion Date :||May 2004|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00067847
|United States, California|
|WestEd-Los Alamitos & UCLA Division of Cancer Prevention and Control Research|
|Los Angeles, California, United States|
|Principal Investigator:||William J McCarthy, Ph.D.||WestEd-Los Alamitos & UCLA Division of Cancer Prevention and Control Research|